Genentech :
Hughes, Sally Smith.
Genentech : the beginnings of biotech Sally Smith Hughes. - London : University of Chicago Press, 2011. - xv, 213 pages : illustrations ; 24 cm. - Synthesis . - Synthesis (University of Chicago. Press) .
Includes bibliographical references and index.
1. Inventing recombinant DNA technology ; Scientists on converging paths ;The collaboration ; Patenting and politics ; Steps toward commercialization -- 2. Creating Genentech ; Bob Swanson ; Founding Genentech ; Legal and political obstacles ; A full business plan -- 3. Proving the technology ; A portentous experiment ; Switching targets ; Negotiating research agreements -- Making somatostatin ; Wider issues -- 4. Human insulin: Genentech makes its mark ; Seeking corporate contracts; Procuring a facility and staff ; Genentech's human insulin project ; The Eli Lilly contract ; Publicity and expansion -- 5. Human growth hormone: shaping a commercial future ; Competing for human growth hormone ; Moving toward corporate integration ; Scaling up insulin and growth hormone ; Corporate expansion ; An emerging culture -- 6. Wall Street debut ; Biomania ; Exit strategies ; Interferon: the new wonder drug? ; Run-up to an initial public offering ; Legal impediments ; The IPO.
9780226045511 (Pbk)
2011004666
Genentech, Inc.--History.
Biotechnology industries--History.--United States
Biotechnology--History.
HD9999.B444 / H85 2011
338.7 H874G
Genentech : the beginnings of biotech Sally Smith Hughes. - London : University of Chicago Press, 2011. - xv, 213 pages : illustrations ; 24 cm. - Synthesis . - Synthesis (University of Chicago. Press) .
Includes bibliographical references and index.
1. Inventing recombinant DNA technology ; Scientists on converging paths ;The collaboration ; Patenting and politics ; Steps toward commercialization -- 2. Creating Genentech ; Bob Swanson ; Founding Genentech ; Legal and political obstacles ; A full business plan -- 3. Proving the technology ; A portentous experiment ; Switching targets ; Negotiating research agreements -- Making somatostatin ; Wider issues -- 4. Human insulin: Genentech makes its mark ; Seeking corporate contracts; Procuring a facility and staff ; Genentech's human insulin project ; The Eli Lilly contract ; Publicity and expansion -- 5. Human growth hormone: shaping a commercial future ; Competing for human growth hormone ; Moving toward corporate integration ; Scaling up insulin and growth hormone ; Corporate expansion ; An emerging culture -- 6. Wall Street debut ; Biomania ; Exit strategies ; Interferon: the new wonder drug? ; Run-up to an initial public offering ; Legal impediments ; The IPO.
9780226045511 (Pbk)
2011004666
Genentech, Inc.--History.
Biotechnology industries--History.--United States
Biotechnology--History.
HD9999.B444 / H85 2011
338.7 H874G